These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 7747984)

  • 1. [Growth of breast cancer and surgery].
    Abe R
    Gan To Kagaku Ryoho; 1995 Apr; 22 Suppl 1():1-9. PubMed ID: 7747984
    [No Abstract]   [Full Text] [Related]  

  • 2. [-Breast neoplasms: axillary lymph node excision--at what price-].
    Rageth JC
    Arch Gynecol Obstet; 1995; 256 Suppl():S85-92. PubMed ID: 8619667
    [No Abstract]   [Full Text] [Related]  

  • 3. Lymph node staging surgery and breast cancer: potholes in the fast lane from more to less.
    Moffat FL
    J Surg Oncol; 2005 Feb; 89(2):53-60. PubMed ID: 15660377
    [No Abstract]   [Full Text] [Related]  

  • 4. Sentinel lymph node as a new marker for therapeutic planning in breast cancer patients.
    Gipponi M; Bassetti C; Canavese G; Catturich A; Di Somma C; Vecchio C; Nicolò G; Schenone F; Tomei D; Cafiero F
    J Surg Oncol; 2004 Mar; 85(3):102-11. PubMed ID: 14991881
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The correlation of extranodal invasion with other prognostic parameters in lymph node positive breast cancer.
    Altinyollar H; Berberoğlu U; Gülben K; Irkin F
    J Surg Oncol; 2007 Jun; 95(7):567-71. PubMed ID: 17226805
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Computer-generated nuclear features compared with axillary lymph node status and tumor size as indicators of breast cancer survival.
    Wolberg WH; Street WN
    Hum Pathol; 2002 Nov; 33(11):1086-91. PubMed ID: 12454812
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advances in axillary surgery for breast cancer--time for a tailored approach.
    Purushotham AD; Macmillan RD; Wishart GC
    Eur J Surg Oncol; 2005 Nov; 31(9):929-31. PubMed ID: 16109469
    [No Abstract]   [Full Text] [Related]  

  • 8. The evolution of lymph node assessment in breast cancer.
    Quan ML; McCready D
    J Surg Oncol; 2009 Mar; 99(4):194-8. PubMed ID: 19021226
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of sentinel lymph node biopsy on lymphedema following breast cancer treatment.
    Soran A; Aydin C; Harlak A; Vogel VG; Johnson R
    Breast J; 2005; 11(5):370-1. PubMed ID: 16174167
    [No Abstract]   [Full Text] [Related]  

  • 10. A high number of tumor free axillary lymph nodes from patients with lymph node negative breast carcinoma is associated with poor outcome.
    Millis RR; Springall RJ; Hanby AM; Ryder K; Fentiman IS
    Cancer; 2002 Apr; 94(8):2307-9. PubMed ID: 12001132
    [No Abstract]   [Full Text] [Related]  

  • 11. Axillary node clearance for breast cancer.
    Thompson AM
    J R Coll Surg Edinb; 1999 Apr; 44(2):111-6. PubMed ID: 10230206
    [No Abstract]   [Full Text] [Related]  

  • 12. Sentinel-node biopsy in breast cancer.
    De Salvo GL; Del Bianco P; Zavagno G
    N Engl J Med; 2003 Nov; 349(20):1968-71; author reply 1968-71. PubMed ID: 14626250
    [No Abstract]   [Full Text] [Related]  

  • 13. Lymphatic mapping and sentinel lymphadenectomy in early stage breast carcinoma.
    Altinyollar H; Kapucuoglu N; Pak I; Berberoglu U
    J Exp Clin Cancer Res; 2000 Jun; 19(2):141-4. PubMed ID: 10965808
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Site size and significance of palpable metastatic and 'reactive' nodes in operable breast cancer.
    Black RB; Steele RJ; Collins WC; Forrest AP
    Clin Oncol; 1982 Jun; 8(2):127-35. PubMed ID: 7105523
    [No Abstract]   [Full Text] [Related]  

  • 15. Comparison of sentinel lymph node biopsy alone and completion axillary lymph node dissection for node-positive breast cancer.
    Bilimoria KY; Bentrem DJ; Hansen NM; Bethke KP; Rademaker AW; Ko CY; Winchester DP; Winchester DJ
    J Clin Oncol; 2009 Jun; 27(18):2946-53. PubMed ID: 19364968
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Management of the axilla in breast cancer: evidences and unresolved issues].
    Fodor J; Polgár C; Péley G; Németh G
    Orv Hetil; 2001 Sep; 142(36):1941-50. PubMed ID: 11680099
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic options and results for the management of minimally invasive carcinoma of the breast: influence of axillary dissection for treatment of T1a and T1b lesions.
    White RE; Vezeridis MP; Konstadoulakis M; Cole BF; Wanebo HJ; Bland KI
    J Am Coll Surg; 1996 Dec; 183(6):575-82. PubMed ID: 8957459
    [TBL] [Abstract][Full Text] [Related]  

  • 18. T1a and T1b breast cancer: a twelve-year experience.
    Visser TJ; Haan M; Keidan R; Lucas R; Ingold J; Glover J; Riggo P
    Am Surg; 1997 Jul; 63(7):621-6. PubMed ID: 9202537
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [-Axillary lymph node excision: for what reasons and indications-].
    Schäfer P
    Arch Gynecol Obstet; 1995; 256 Suppl():S81-4. PubMed ID: 8619666
    [No Abstract]   [Full Text] [Related]  

  • 20. [The prognostic significance of axillary node metastasis in breast cancer].
    Miura S
    Gan To Kagaku Ryoho; 1996 Mar; 23 Suppl 1():36-42. PubMed ID: 8702309
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.